March 24, 2020 / 1:18 AM / 16 days ago

BRIEF-Paradigm Biopharmaceuticals Says Extended Access Program Remains On-Track

March 24 (Reuters) - Paradigm Biopharmaceuticals Ltd :

* EXTENDED ACCESS PROGRAM REMAINS ON-TRACK WITH PARADIGM EXPECTING TO REPORT RESULTS TO MARKET Q3 CY2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below